News

The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.
On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...
FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.
This expansion represents a robust Compound Annual Growth Rate (CAGR) of approximately 11.20% during the forecast period from 2025 to 2034. This remarkable growth is fueled by a confluence of factors: ...
For decades, cancer has been spoken of in hushed tones across the world, a death sentence for millions, especially in regions ...
LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire / -- How Big Is The Human Serum Albumin Market In 2025?
Aging research is increasingly focused on proteins that regulate DNA repair, metabolism, cell survival and tissue renewal.
Beta-lactoglobulin, the most abundant whey protein in dairy, outperforms other forms of whey and casein—precision ...
Research in animal models and human cells has indicated that Neuritin 1 could be a new target for obesity drugs, making it ...
CollPlant Biotechnologies (NASDAQ: CLGN), or ‘ CollPlant ‘, a regenerative and aesthetics medicine company developing ...
Kópavogur, Iceland-based ORF Genetics, a plant biotechnology company, has raised €5M to expand its MESOkine growth-factor portfolio.
Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded ...